skip to main content

S. 2252: Empowering States to Address Drug Costs Act

The text of the bill below is as of Jul 24, 2019 (Introduced).


II

116th CONGRESS

1st Session

S. 2252

IN THE SENATE OF THE UNITED STATES

July 24, 2019

(for himself and Mr. Cardin) introduced the following bill; which was read twice and referred to the Committee on Finance

A BILL

To amend title XIX of the Social Security Act to expand the permitted uses of drug price information disclosed to States under the Medicaid drug rebate program.

1.

Short title

This Act may be cited as the Empowering States to Address Drug Costs Act.

2.

Expansion of permitted uses of drug price information disclosed to States under Medicaid drug rebate program

Clause (iv) of section 1927(b)(3)(D) of the Social Security Act (42 U.S.C. 1396r–8(b)(3)(D)) is amended to read as follows:

(iv)

to States—

(I)

to carry out this title, or

(II)

to review the information provided (including average manufacturer price, best price, and rebate calculation data) for the purposes of establishing and operating State all-payer prescription drug rate setting entities (drug affordability boards) or State multi-payer purchasing pools,

.